Siga Technologies INC Accounts Payable and Accrued Liabilities
Siga Technologies INC (SIGA) had Accounts Payable and Accrued Liabilities of $43.63 thousand as of 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2016-08-08
- 2016-06-30: Accounts Payable and Accrued Liabilities $43.63K.
- 2016-03-31: Accounts Payable and Accrued Liabilities $2.45M.
- 2015-12-31: Accounts Payable and Accrued Liabilities $842.92K.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2016-06-30 | $43.63K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $2.45M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $842.92K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |